PWWP2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.779600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.286400E-01
Normal-vs-Stage2
5.419400E-01
Normal-vs-Stage3
7.917600E-02
Normal-vs-Stage4
9.608600E-01
Stage1-vs-Stage2
2.205600E-01
Stage1-vs-Stage3
9.002200E-03
Stage1-vs-Stage4
8.654200E-01
Stage2-vs-Stage3
4.048100E-02
Stage2-vs-Stage4
4.286600E-01
Stage3-vs-Stage4
5.003700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.949200E-01
Normal-vs-AfricanAmerican
4.197200E-01
Normal-vs-Asian
5.867000E-01
Caucasian-vs-AfricanAmerican
5.465200E-01
Caucasian-vs-Asian
6.512400E-01
AfricanAmerican-vs-Asian
8.559200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.974800E-01
Normal-vs-Female
5.761600E-01
Male-vs-Female
8.836200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.310200E-01
Normal-vs-Age(41-60Yrs)
9.612400E-01
Normal-vs-Age(61-80Yrs)
4.139200E-01
Normal-vs-Age(81-100Yrs)
2.069200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.575200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.424800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.404000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.137600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.128200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.332600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.319200E-01
Normal-vs-Daily Drinker
4.711200E-01
Normal-vs-Weekly Drinker
3.263800E-01
Normal-vs-Occasional Drinker
9.605800E-01
Normal-vs-Social Drinker
7.845600E-01
Non Drinker-vs-Daily Drinker
7.070000E-01
Non Drinker-vs-Weekly Drinker
3.772000E-01
Non Drinker-vs-Occasional Drinker
1.863810E-01
Non Drinker-vs-Social Drinker
5.155600E-01
Daily Drinker-vs-Weekly Drinker
6.239800E-01
Daily Drinker-vs-Occasional Drinker
1.395790E-01
Daily Drinker-vs-Social Drinker
3.741800E-01
Weekly Drinker-vs-Occasional Drinker
7.533800E-02
Weekly Drinker-vs-Social Drinker
1.951960E-01
Occasional Drinker-vs-Social Drinker
5.709000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.599600E-02
Normal-vs-Grade 2
1.916680E-03
Normal-vs-Grade 3
5.823700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.842400E-01
Grade 1-vs-Grade 3
1.698440E-01
Grade 1-vs-Grade 4
6.599600E-02
Grade 2-vs-Grade 3
1.594360E-01
Grade 2-vs-Grade 4
1.916680E-03
Grade 3-vs-Grade 4
5.823700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.451600E-01
Normal-vs-NonDiabetic
6.052400E-01
Diabetic-vs-NonDiabetic
2.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.858200E-01
Normal-vs-NoPancreatitis
5.201000E-01
Pancreatitis-vs-NoPancreatitis
7.434200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.906600E-01
Normal-vs-N1
5.290600E-01
N0-vs-N1
5.286000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.930800E-01
Normal-vs-TP53-NonMutant
9.049600E-01
TP53-Mutant-vs-TP53-NonMutant
9.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
